Topical CBD for Skin Conditions: Anti-inflammatory, Anti-itch, and Wound Healing Effects
A review found growing evidence that topical CBD has anti-inflammatory, anti-itch, analgesic, wound healing, and anti-proliferative effects on skin through cannabinoid receptors.
Quick Facts
What This Study Found
With the discovery of cannabinoid receptors on the skin, topical cannabis has demonstrated anti-inflammatory, anti-itching, analgesic, wound healing, and anti-proliferative effects. CBD is being explored as a potential alternative to topical corticosteroids for some dermatological conditions.
Key Numbers
Over 500 biologically active components in cannabis; over 100 phytocannabinoids identified; 3 primary cannabis species (sativa, indica, ruderalis)
How They Did This
Comprehensive review of literature on topical CBD for dermatological applications, covering the endocannabinoid system in skin, cannabinoid receptor distribution, and evidence for specific skin conditions.
Why This Research Matters
Topical corticosteroids are the mainstay treatment for many skin conditions but carry significant side effects with long-term use. Topical CBD could offer a safer alternative if clinical evidence supports it.
The Bigger Picture
The skin has its own endocannabinoid system with functional cannabinoid receptors, providing biological plausibility for topical CBD effects. Research is early but the dermatological applications are expanding.
What This Study Doesn't Tell Us
Review primarily describes mechanisms and rationale rather than clinical trial results. Most evidence comes from preclinical or early-stage studies.
Questions This Raises
- ?Which specific skin conditions respond best to topical CBD?
- ?What concentrations and formulations are needed for clinical efficacy?
Trust & Context
- Key Stat:
- Cannabinoid receptors found on skin cells
- Evidence Grade:
- Review of predominantly preclinical evidence. Clinical trial data for topical CBD in dermatology remains limited.
- Study Age:
- Published in 2022
- Original Title:
- Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.
- Published In:
- South African family practice : official journal of the South African Academy of Family Practice/Primary Care, 64(1), e1-e4 (2022)
- Authors:
- Makhakhe, Lehlohonolo
- Database ID:
- RTHC-04030
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does topical CBD work for skin conditions?
The review found evidence of anti-inflammatory, anti-itch, analgesic, wound healing, and anti-proliferative effects from topical CBD. However, most evidence is preclinical and large clinical trials are still needed.
Could CBD replace topical steroids?
The review suggests CBD could be a safer alternative to corticosteroids for some skin conditions, but clinical evidence is still in early stages and more research is needed to support this transition.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04030APA
Makhakhe, Lehlohonolo. (2022). Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.. South African family practice : official journal of the South African Academy of Family Practice/Primary Care, 64(1), e1-e4. https://doi.org/10.4102/safp.v64i1.5493
MLA
Makhakhe, Lehlohonolo. "Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.." South African family practice : official journal of the South African Academy of Family Practice/Primary Care, 2022. https://doi.org/10.4102/safp.v64i1.5493
RethinkTHC
RethinkTHC Research Database. "Topical cannabidiol (CBD) in skin pathology - A comprehensiv..." RTHC-04030. Retrieved from https://rethinkthc.com/research/makhakhe-2022-topical-cannabidiol-cbd-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.